Share your contact details to receive free updated sample copy/pages of the recently published edition of Veterinary Vaccine Market Report 2023.
Key Insights from Veterinary Vaccine Market Report
As per Cognitive Market Research's latest published report, the Global Veterinary Vaccine market size was $8,486.5 million in 2022. Veterinary Vaccine Industry's Compound Annual Growth Rate will be 6.1% from 2023 to 2030.
Veterinary Vaccine Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Veterinary Vaccine Market Report Description
What is Veterinary Vaccine?
Veterinary vaccines are essential for preventing diseases from spreading and protecting both animal and human health, which is critical given the public's reliance on animals. Animals are the source of all human food, milk, protein, and industrial goods like leather and wool. Vaccinations against rabies, foot-and-mouth disease, and the equine influenza virus are some of the most often used veterinary vaccines that prevent the spread of infectious pathogens by duplicating naturally acquired immunity.
Factors Impacting on Veterinary Vaccine Market
Growth in pet adoption will fuel demand for animal vaccines, which propel the growth of the global veterinary vaccines market. In addition, the rising level of expenditure for pet healthcare dominates the global veterinary-animal vaccines market growth. Furthermore, the rise in the prevalence of foodborne and zoonotic diseases drives the demand for the global market.
-
Global Veterinary Vaccine Market Opportunity
technological advancement in the development of animal health vaccines and an increase in the number of emerging markets will provide opportunities for the veterinary-animal vaccines market growth.
-
Global Veterinary Vaccine Market Restraints
The high cost associated with the vaccine and the lack of well-established infrastructure in emerging countries.
Veterinary Vaccine Market Report 2023 (Global Edition) Table of Content differs according to the user License selection. Current Displayed TOC is for the Single User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report. Specific section/s of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
- 1.1 Global Veterinary Vaccine Industry Introduction
- 1.2 Objectives of the Study
- 1.3 USP of the Report
- 1.4 Who is this report for?
- 1.5 Designing of Market Scope
- 1.5.1 Veterinary Vaccine Market Segmentation
- 1.5.1 Veterinary Vaccine Market Regional Fragmentation
- 1.5.1 Veterinary Vaccine Market Players
- 1.6 Report Duration
- 1.7 List of Stakeholders
- 2.1 Veterinary Vaccine Market Report 2023 Research Methodology
- 2.2 Systematic Research Approach
- 2.2.1 Primary Research
- 2.2.1.1 Key Data from Primary
- 2.2.1.2 Primary Interviews with Experts
- 2.2.1.3 Key Industry Insights
- 2.2.1.4 Questionnaire
At Cognitive Market Research, we have designed questionnaire focused on Veterinary Vaccine Market for the statistical study. This questionnaire is the key part of our research methodology which is shared with number of Veterinary Vaccine industry experts of entire value chain, located across the globe. This study help us to gather accurate quantitative and qualitative data for the final report.
- 2.2.1.5 Breakdown of Primaries
- 2.2.2 Secondary Research
- 2.2.2.1 Key Data from Secondary
- 2.2.2.2 Paid Sources
- 2.2.2.3 Public Sources
- 2.2.1 Primary Research
- 2.3 Market Size Estimation
- 2.3.1 Top-Down Approach
- 2.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 2.3.1 Bottom-UP Approach
- 2.3.1.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 2.3.1 Top-Down Approach
- 2.4 Market Breakdown and Data Triangulation
- 2.5 Research Assumptions
- 3.1 Global Veterinary Vaccine Market Size 2018 – 2030, (USD Million)
- 3.2 Global Veterinary Vaccine Value, Absolute & Opportunity Analysis
- 3.3 Global Veterinary Vaccine Market Y-o-Y Growth Rate Projection by Region (2023 - 2030)
- 3.4 Global Veterinary Vaccine Market Statistics 2022: Snapshot
- 4.1 Veterinary Vaccine Introduction
- 4.2 Global Veterinary Vaccine Market Statistics by Regions (2018-2030)
- 4.2.1 North America Veterinary Vaccine Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.2 Europe Veterinary Vaccine Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.3 Asia Pacific Veterinary Vaccine Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.4 Latin America Veterinary Vaccine Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.5 Middle East and Africa Veterinary Vaccine Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.3 Global Veterinary Vaccine Market Size (2018-2030)
- 4.3.1 Global Veterinary Vaccine Revenue Status and Outlook (2018-2030)
- 4.4 Global Veterinary Vaccine Market Price Analysis by Regions (2018-2030)
- 5.1 Global Veterinary Vaccine Market Revenue and Share by Manufacturers (2018-2022)
- 5.2 Global Veterinary Vaccine Industry Mergers and Acquisition Analysis
- 5.3 Global Veterinary Vaccine New Launches Analysis
- 5.4 Company Categorization
- 5.5 Global Veterinary Vaccine Top Winning Strategies, by Manufacturers (2018-2022)
- 7.1 Veterinary Vaccine Industrial Dynamics
- 7.1.1 Global Veterinary Vaccine Market Drivers
- 7.1.2 Global Veterinary Vaccine Market Restrains
- 7.1.3 Global Veterinary Vaccine Market Opportunities
- 7.1.4 Global Veterinary Vaccine Market Trends
- 7.2 Veterinary Vaccine Market Attractiveness Analysis
- 7.1.1 Market Attractiveness Analysis by Type Segment
- 7.1.2 Market Attractiveness Analysis by Application Segment
- 7.3 PESTEL Analysis for Veterinary Vaccine Market
- 7.3.1 Political Factors
- 7.3.2 Economic Factors
- 7.3.3 Social Factors
- 7.3.4 Technological Factors
- 7.3.5 Legal Factors
- 7.3.6 Environmental Factors
- 7.4 Porter’s Five Forces Analysis for Veterinary Vaccine Market
- 7.4.1 Bargaining Power of Suppliers
- 7.4.2 Bargaining Power of Buyers
- 7.4.3 Threat of Substitutes
- 7.4.4 Threat of New Entrants
- 7.4.5 Degree of Competition
- 7.5 COVID-19 Impact on Veterinary Vaccine Industry
- 7.4.1 Overall Impact of COVID-19 on Veterinary Vaccine Industry
- 7.4.2 Post COVID-19 Impact and Recovery Analysis
- 7.4.3 Influencing Factors
- 7.6 Consumer Preference Analysis for Veterinary Vaccine Market
- 7.7 Patent Analysis of Veterinary Vaccine
- 7.8 Veterinary Vaccine Industrial Chain Analysis
- 7.9 Manufacturing Cost Analysis
- 8.1 Merial
- 8.1.1 Merial Company Basic Information, and Sales Area
- 8.1.2 Merial Business Segment/ Overview
- 8.1.3 Merial Financials
- 8.1.3.1 Investment in Research and Development
- 8.1.3.2 Merial Sales Revenue (2018-2022)
- 8.1.3.3 Merial Market Share (2018-2022)
- 8.1.4 Merial Recent Developments
- 8.1.5 Merial Business Strategy
- 8.1.6 Merial Management Change
- 8.1.7 Merial SWOT Analysis
- 8.1.7.1 Strength
- 8.1.7.2 Weakness
- 8.1.7.3 Opportunity
- 8.1.7.4 Threats
- 8.1.8 Merial COVID-19 Impact Analysis
- 8.2 Merck
- 8.2.1 Merck Company Basic Information, and Sales Area
- 8.2.2 Merck Business Segment/ Overview
- 8.2.3 Merck Financials
- 8.2.3.1 Investment in Research and Development
- 8.2.3.2 Merck Sales Revenue (2018-2022)
- 8.2.3.3 Merck Market Share (2018-2022)
- 8.2.4 Merck Recent Developments
- 8.2.5 Merck Business Strategy
- 8.2.6 Merck Management Change
- 8.2.7 Merck SWOT Analysis
- 8.2.7.1 Strength
- 8.2.7.2 Weakness
- 8.2.7.3 Opportunity
- 8.2.7.4 Threats
- 8.2.8 Merck COVID-19 Impact Analysis
- 8.3 Boehringer Ingelheim
- 8.3.1 Boehringer Ingelheim Company Basic Information, and Sales Area
- 8.3.2 Boehringer Ingelheim Business Segment/ Overview
- 8.3.3 Boehringer Ingelheim Financials
- 8.3.3.1 Investment in Research and Development
- 8.3.3.2 Boehringer Ingelheim Sales Revenue (2018-2022)
- 8.3.3.3 Boehringer Ingelheim Market Share (2018-2022)
- 8.3.4 Boehringer Ingelheim Recent Developments
- 8.3.5 Boehringer Ingelheim Business Strategy
- 8.3.6 Boehringer Ingelheim Management Change
- 8.3.7 Boehringer Ingelheim SWOT Analysis
- 8.3.7.1 Strength
- 8.3.7.2 Weakness
- 8.3.7.3 Opportunity
- 8.3.7.4 Threats
- 8.3.8 Boehringer Ingelheim COVID-19 Impact Analysis
- 8.4 Zoetis
- 8.4.1 Zoetis Company Basic Information, and Sales Area
- 8.4.2 Zoetis Business Segment/ Overview
- 8.4.3 Zoetis Financials
- 8.4.3.1 Investment in Research and Development
- 8.4.3.2 Zoetis Sales Revenue (2018-2022)
- 8.4.3.3 Zoetis Market Share (2018-2022)
- 8.4.4 Zoetis Recent Developments
- 8.4.5 Zoetis Business Strategy
- 8.4.6 Zoetis Management Change
- 8.4.7 Zoetis SWOT Analysis
- 8.4.7.1 Strength
- 8.4.7.2 Weakness
- 8.4.7.3 Opportunity
- 8.4.7.4 Threats
- 8.4.8 Zoetis COVID-19 Impact Analysis
- 8.5 Virbac
- 8.5.1 Virbac Company Basic Information, and Sales Area
- 8.5.2 Virbac Business Segment/ Overview
- 8.5.3 Virbac Financials
- 8.5.3.1 Investment in Research and Development
- 8.5.3.2 Virbac Sales Revenue (2018-2022)
- 8.5.3.3 Virbac Market Share (2018-2022)
- 8.5.4 Virbac Recent Developments
- 8.5.5 Virbac Business Strategy
- 8.5.6 Virbac Management Change
- 8.5.7 Virbac SWOT Analysis
- 8.5.7.1 Strength
- 8.5.7.2 Weakness
- 8.5.7.3 Opportunity
- 8.5.7.4 Threats
- 8.5.8 Virbac COVID-19 Impact Analysis
- 8.6 Ceva
- 8.6.1 Ceva Company Basic Information, and Sales Area
- 8.6.2 Ceva Business Segment/ Overview
- 8.6.3 Ceva Financials
- 8.6.3.1 Investment in Research and Development
- 8.6.3.2 Ceva Sales Revenue (2018-2022)
- 8.6.3.3 Ceva Market Share (2018-2022)
- 8.6.4 Ceva Recent Developments
- 8.6.5 Ceva Business Strategy
- 8.6.6 Ceva Management Change
- 8.6.7 Ceva SWOT Analysis
- 8.6.7.1 Strength
- 8.6.7.2 Weakness
- 8.6.7.3 Opportunity
- 8.6.7.4 Threats
- 8.6.8 Ceva COVID-19 Impact Analysis
- 8.7 Elanco/Eli Lilly
- 8.7.1 Elanco/Eli Lilly Company Basic Information, and Sales Area
- 8.7.2 Elanco/Eli Lilly Business Segment/ Overview
- 8.7.3 Elanco/Eli Lilly Financials
- 8.7.3.1 Investment in Research and Development
- 8.7.3.2 Elanco/Eli Lilly Sales Revenue (2018-2022)
- 8.7.3.3 Elanco/Eli Lilly Market Share (2018-2022)
- 8.7.4 Elanco/Eli Lilly Recent Developments
- 8.7.5 Elanco/Eli Lilly Business Strategy
- 8.7.6 Elanco/Eli Lilly Management Change
- 8.7.7 Elanco/Eli Lilly SWOT Analysis
- 8.7.7.1 Strength
- 8.7.7.2 Weakness
- 8.7.7.3 Opportunity
- 8.7.7.4 Threats
- 8.7.8 Elanco/Eli Lilly COVID-19 Impact Analysis
- 8.8 Sindh Poultry Vaccine Centre
- 8.8.1 Sindh Poultry Vaccine Centre Company Basic Information, and Sales Area
- 8.8.2 Sindh Poultry Vaccine Centre Business Segment/ Overview
- 8.8.3 Sindh Poultry Vaccine Centre Financials
- 8.8.3.1 Investment in Research and Development
- 8.8.3.2 Sindh Poultry Vaccine Centre Sales Revenue (2018-2022)
- 8.8.3.3 Sindh Poultry Vaccine Centre Market Share (2018-2022)
- 8.8.4 Sindh Poultry Vaccine Centre Recent Developments
- 8.8.5 Sindh Poultry Vaccine Centre Business Strategy
- 8.8.6 Sindh Poultry Vaccine Centre Management Change
- 8.8.7 Sindh Poultry Vaccine Centre SWOT Analysis
- 8.8.7.1 Strength
- 8.8.7.2 Weakness
- 8.8.7.3 Opportunity
- 8.8.7.4 Threats
- 8.8.8 Sindh Poultry Vaccine Centre COVID-19 Impact Analysis
- 8.9 Bio Labs
- 8.9.1 Bio Labs Company Basic Information, and Sales Area
- 8.9.2 Bio Labs Business Segment/ Overview
- 8.9.3 Bio Labs Financials
- 8.9.3.1 Investment in Research and Development
- 8.9.3.2 Bio Labs Sales Revenue (2018-2022)
- 8.9.3.3 Bio Labs Market Share (2018-2022)
- 8.9.4 Bio Labs Recent Developments
- 8.9.5 Bio Labs Business Strategy
- 8.9.6 Bio Labs Management Change
- 8.9.7 Bio Labs SWOT Analysis
- 8.9.7.1 Strength
- 8.9.7.2 Weakness
- 8.9.7.3 Opportunity
- 8.9.7.4 Threats
- 8.9.8 Bio Labs COVID-19 Impact Analysis
- 8.10 Vaksindo
- 8.10.1 Vaksindo Company Basic Information, and Sales Area
- 8.10.2 Vaksindo Business Segment/ Overview
- 8.10.3 Vaksindo Financials
- 8.10.3.1 Investment in Research and Development
- 8.10.3.2 Vaksindo Sales Revenue (2018-2022)
- 8.10.3.3 Vaksindo Market Share (2018-2022)
- 8.10.4 Vaksindo Recent Developments
- 8.10.5 Vaksindo Business Strategy
- 8.10.6 Vaksindo Management Change
- 8.10.7 Vaksindo SWOT Analysis
- 8.10.7.1 Strength
- 8.10.7.2 Weakness
- 8.10.7.3 Opportunity
- 8.10.7.4 Threats
- 8.10.8 Vaksindo COVID-19 Impact Analysis
- 9.1 Detailed Qualitative Analysis
- 9.2 Global Veterinary Vaccine Revenue and Share (%) by Technology (2018-2030)
- 9.2.1 Inactivated Vaccines Market Size
- 9.2.1.1 Global Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 9.2.1.2 Veterinary Vaccine Market for Inactivated Vaccines, by Country (2021 Vs 2024)
- 9.2.2 Toxoid Vaccine Market Size
- 9.2.2.1 Global Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 9.2.2.2 Veterinary Vaccine Market for Toxoid Vaccine, by Country (2021 Vs 2024)
- 9.2.3 Live Attenuated Vaccines Market Size
- 9.2.3.1 Global Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 9.2.3.2 Veterinary Vaccine Market for Live Attenuated Vaccines, by Country (2021 Vs 2024)
- 9.2.4 Subunit and DNA Vaccines Market Size
- 9.2.4.1 Global Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 9.2.4.2 Veterinary Vaccine Market for Subunit and DNA Vaccines, by Country (2021 Vs 2024)
- 9.2.1 Inactivated Vaccines Market Size
- 10.1 Detailed Qualitative Analysis
- 10.2 Global Veterinary Vaccine Revenue and Share (%) by Animal Type (2018-2030)
- 10.2.1 Companion Market Size
- 10.2.1.1 Global Companion Market Share and Revenue (USD Million) for 2018-2030
- 10.2.1.2 Veterinary Vaccine Market for Companion, by Country (2021 Vs 2024)
- 10.2.2 Livestock Market Size
- 10.2.2.1 Global Livestock Market Share and Revenue (USD Million) for 2018-2030
- 10.2.2.2 Veterinary Vaccine Market for Livestock, by Country (2021 Vs 2024)
- 10.2.1 Companion Market Size
- 11.1 Detailed Qualitative Analysis
- 11.2 Global Veterinary Vaccine Market Revenue by Region (2018-2030)
- 11.3 Global Veterinary Vaccine Market Share (%) by Region (2018-2030)
- 12.1 North America
- 12.1.1 North America Veterinary Vaccine Market Trends and Analysis
- 12.1.2 North America Veterinary Vaccine Market by Country, 2018-2030
- 12.1.3 North America Veterinary Vaccine Market Attractiveness Analysis by Country
- 12.2 North America Veterinary Vaccine Market Size (2018-2030)
- 12.2.1 North America Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 12.2.1.1 Inactivated Vaccines
- 12.2.1.1.1 North America Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 12.2.1.2 Toxoid Vaccine
- 12.2.1.2.1 North America Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 12.2.1.3 Live Attenuated Vaccines
- 12.2.1.3.1 North America Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 12.2.1.4 Subunit and DNA Vaccines
- 12.2.1.4.1 North America Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 12.2.1.1 Inactivated Vaccines
- 12.2.2 North America Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 12.2.2.1 Companion
- 12.2.2.1.1 North America Companion Market Share and Revenue (USD Million) for 2018-2030
- 12.2.2.2 Livestock
- 12.2.2.2.1 North America Livestock Market Share and Revenue (USD Million) for 2018-2030
- 12.2.2.1 Companion
- 12.2.1 North America Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 12.3 United States Veterinary Vaccine Market Size (2018-2030)
- 12.3.1 United States Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 12.3.1.1 Inactivated Vaccines
- 12.3.1.1.1 United States Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 12.3.1.2 Toxoid Vaccine
- 12.3.1.2.1 United States Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 12.3.1.3 Live Attenuated Vaccines
- 12.3.1.3.1 United States Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 12.3.1.4 Subunit and DNA Vaccines
- 12.3.1.4.1 United States Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 12.3.1.1 Inactivated Vaccines
- 12.3.2 United States Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 12.3.2.1 Companion
- 12.3.2.1.1 United States Companion Market Share and Revenue (USD Million) for 2018-2030
- 12.3.2.2 Livestock
- 12.3.2.2.1 United States Livestock Market Share and Revenue (USD Million) for 2018-2030
- 12.3.2.1 Companion
- 12.3.1 United States Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 12.4 Canada Veterinary Vaccine Market Size (2018-2030)
- 12.4.1 Canada Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 12.4.1.1 Inactivated Vaccines
- 12.4.1.1.1 Canada Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 12.4.1.2 Toxoid Vaccine
- 12.4.1.2.1 Canada Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 12.4.1.3 Live Attenuated Vaccines
- 12.4.1.3.1 Canada Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 12.4.1.4 Subunit and DNA Vaccines
- 12.4.1.4.1 Canada Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 12.4.1.1 Inactivated Vaccines
- 12.4.2 Canada Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 12.4.2.1 Companion
- 12.4.2.1.1 Canada Companion Market Share and Revenue (USD Million) for 2018-2030
- 12.4.2.2 Livestock
- 12.4.2.2.1 Canada Livestock Market Share and Revenue (USD Million) for 2018-2030
- 12.4.2.1 Companion
- 12.4.1 Canada Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 12.5 Mexico Veterinary Vaccine Market Size (2018-2030)
- 12.5.1 Mexico Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 12.5.1.1 Inactivated Vaccines
- 12.5.1.1.1 Mexico Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 12.5.1.2 Toxoid Vaccine
- 12.5.1.2.1 Mexico Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 12.5.1.3 Live Attenuated Vaccines
- 12.5.1.3.1 Mexico Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 12.5.1.4 Subunit and DNA Vaccines
- 12.5.1.4.1 Mexico Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 12.5.1.1 Inactivated Vaccines
- 12.5.2 Mexico Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 12.5.2.1 Companion
- 12.5.2.1.1 Mexico Companion Market Share and Revenue (USD Million) for 2018-2030
- 12.5.2.2 Livestock
- 12.5.2.2.1 Mexico Livestock Market Share and Revenue (USD Million) for 2018-2030
- 12.5.2.1 Companion
- 12.5.1 Mexico Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.1 Europe
- 13.1.1 Europe Veterinary Vaccine Market Trends and Analysis
- 13.1.2 Europe Veterinary Vaccine Market by Country, 2018-2030
- 13.1.3 Europe Veterinary Vaccine Market Attractiveness Analysis by Country
- 13.2 Europe Veterinary Vaccine Market Size (2018-2030)
- 13.2.1 Europe Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.2.1.1 Inactivated Vaccines
- 13.2.1.1.1 Europe Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.2 Toxoid Vaccine
- 13.2.1.2.1 Europe Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.3 Live Attenuated Vaccines
- 13.2.1.3.1 Europe Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.4 Subunit and DNA Vaccines
- 13.2.1.4.1 Europe Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.1 Inactivated Vaccines
- 13.2.2 Europe Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 13.2.2.1 Companion
- 13.2.2.1.1 Europe Companion Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.2 Livestock
- 13.2.2.2.1 Europe Livestock Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.1 Companion
- 13.2.1 Europe Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.3 United Kingdom Veterinary Vaccine Market Size (2018-2030)
- 13.3.1 United Kingdom Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.3.1.1 Inactivated Vaccines
- 13.3.1.1.1 United Kingdom Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.3.1.2 Toxoid Vaccine
- 13.3.1.2.1 United Kingdom Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 13.3.1.3 Live Attenuated Vaccines
- 13.3.1.3.1 United Kingdom Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.3.1.4 Subunit and DNA Vaccines
- 13.3.1.4.1 United Kingdom Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.3.1.1 Inactivated Vaccines
- 13.3.2 United Kingdom Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 13.3.2.1 Companion
- 13.3.2.1.1 United Kingdom Companion Market Share and Revenue (USD Million) for 2018-2030
- 13.3.2.2 Livestock
- 13.3.2.2.1 United Kingdom Livestock Market Share and Revenue (USD Million) for 2018-2030
- 13.3.2.1 Companion
- 13.3.1 United Kingdom Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.4 France Veterinary Vaccine Market Size (2018-2030)
- 13.4.1 France Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.4.1.1 Inactivated Vaccines
- 13.4.1.1.1 France Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.4.1.2 Toxoid Vaccine
- 13.4.1.2.1 France Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 13.4.1.3 Live Attenuated Vaccines
- 13.4.1.3.1 France Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.4.1.4 Subunit and DNA Vaccines
- 13.4.1.4.1 France Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.4.1.1 Inactivated Vaccines
- 13.4.2 France Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 13.4.2.1 Companion
- 13.4.2.1.1 France Companion Market Share and Revenue (USD Million) for 2018-2030
- 13.4.2.2 Livestock
- 13.4.2.2.1 France Livestock Market Share and Revenue (USD Million) for 2018-2030
- 13.4.2.1 Companion
- 13.4.1 France Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.5 Germany Veterinary Vaccine Market Size (2018-2030)
- 13.5.1 Germany Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.5.1.1 Inactivated Vaccines
- 13.5.1.1.1 Germany Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.5.1.2 Toxoid Vaccine
- 13.5.1.2.1 Germany Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 13.5.1.3 Live Attenuated Vaccines
- 13.5.1.3.1 Germany Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.5.1.4 Subunit and DNA Vaccines
- 13.5.1.4.1 Germany Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.5.1.1 Inactivated Vaccines
- 13.5.2 Germany Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 13.5.2.1 Companion
- 13.5.2.1.1 Germany Companion Market Share and Revenue (USD Million) for 2018-2030
- 13.5.2.2 Livestock
- 13.5.2.2.1 Germany Livestock Market Share and Revenue (USD Million) for 2018-2030
- 13.5.2.1 Companion
- 13.5.1 Germany Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.6 Italy Veterinary Vaccine Market Size (2018-2030)
- 13.6.1 Italy Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.6.1.1 Inactivated Vaccines
- 13.6.1.1.1 Italy Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.6.1.2 Toxoid Vaccine
- 13.6.1.2.1 Italy Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 13.6.1.3 Live Attenuated Vaccines
- 13.6.1.3.1 Italy Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.6.1.4 Subunit and DNA Vaccines
- 13.6.1.4.1 Italy Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.6.1.1 Inactivated Vaccines
- 13.6.2 Italy Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 13.6.2.1 Companion
- 13.6.2.1.1 Italy Companion Market Share and Revenue (USD Million) for 2018-2030
- 13.6.2.2 Livestock
- 13.6.2.2.1 Italy Livestock Market Share and Revenue (USD Million) for 2018-2030
- 13.6.2.1 Companion
- 13.6.1 Italy Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.7 Russia Veterinary Vaccine Market Size (2018-2030)
- 13.7.1 Russia Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.7.1.1 Inactivated Vaccines
- 13.7.1.1.1 Russia Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.7.1.2 Toxoid Vaccine
- 13.7.1.2.1 Russia Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 13.7.1.3 Live Attenuated Vaccines
- 13.7.1.3.1 Russia Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.7.1.4 Subunit and DNA Vaccines
- 13.7.1.4.1 Russia Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.7.1.1 Inactivated Vaccines
- 13.7.2 Russia Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 13.7.2.1 Companion
- 13.7.2.1.1 Russia Companion Market Share and Revenue (USD Million) for 2018-2030
- 13.7.2.2 Livestock
- 13.7.2.2.1 Russia Livestock Market Share and Revenue (USD Million) for 2018-2030
- 13.7.2.1 Companion
- 13.7.1 Russia Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.8 Spain Veterinary Vaccine Market Size (2018-2030)
- 13.8.1 Spain Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.8.1.1 Inactivated Vaccines
- 13.8.1.1.1 Spain Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.8.1.2 Toxoid Vaccine
- 13.8.1.2.1 Spain Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 13.8.1.3 Live Attenuated Vaccines
- 13.8.1.3.1 Spain Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.8.1.4 Subunit and DNA Vaccines
- 13.8.1.4.1 Spain Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.8.1.1 Inactivated Vaccines
- 13.8.2 Spain Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 13.8.2.1 Companion
- 13.8.2.1.1 Spain Companion Market Share and Revenue (USD Million) for 2018-2030
- 13.8.2.2 Livestock
- 13.8.2.2.1 Spain Livestock Market Share and Revenue (USD Million) for 2018-2030
- 13.8.2.1 Companion
- 13.8.1 Spain Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.9 Sweden Veterinary Vaccine Market Size (2018-2030)
- 13.9.1 Sweden Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.9.1.1 Inactivated Vaccines
- 13.9.1.1.1 Sweden Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.9.1.2 Toxoid Vaccine
- 13.9.1.2.1 Sweden Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 13.9.1.3 Live Attenuated Vaccines
- 13.9.1.3.1 Sweden Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.9.1.4 Subunit and DNA Vaccines
- 13.9.1.4.1 Sweden Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.9.1.1 Inactivated Vaccines
- 13.9.2 Sweden Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 13.9.2.1 Companion
- 13.9.2.1.1 Sweden Companion Market Share and Revenue (USD Million) for 2018-2030
- 13.9.2.2 Livestock
- 13.9.2.2.1 Sweden Livestock Market Share and Revenue (USD Million) for 2018-2030
- 13.9.2.1 Companion
- 13.9.1 Sweden Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.10 Denmark Veterinary Vaccine Market Size (2018-2030)
- 13.10.1 Denmark Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.10.1.1 Inactivated Vaccines
- 13.10.1.1.1 Denmark Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.10.1.2 Toxoid Vaccine
- 13.10.1.2.1 Denmark Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 13.10.1.3 Live Attenuated Vaccines
- 13.10.1.3.1 Denmark Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.10.1.4 Subunit and DNA Vaccines
- 13.10.1.4.1 Denmark Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.10.1.1 Inactivated Vaccines
- 13.10.2 Denmark Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 13.10.2.1 Companion
- 13.10.2.1.1 Denmark Companion Market Share and Revenue (USD Million) for 2018-2030
- 13.10.2.2 Livestock
- 13.10.2.2.1 Denmark Livestock Market Share and Revenue (USD Million) for 2018-2030
- 13.10.2.1 Companion
- 13.10.1 Denmark Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.11 Netherlands Veterinary Vaccine Market Size (2018-2030)
- 13.11.1 Netherlands Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.11.1.1 Inactivated Vaccines
- 13.11.1.1.1 Netherlands Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.11.1.2 Toxoid Vaccine
- 13.11.1.2.1 Netherlands Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 13.11.1.3 Live Attenuated Vaccines
- 13.11.1.3.1 Netherlands Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.11.1.4 Subunit and DNA Vaccines
- 13.11.1.4.1 Netherlands Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.11.1.1 Inactivated Vaccines
- 13.11.2 Netherlands Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 13.11.2.1 Companion
- 13.11.2.1.1 Netherlands Companion Market Share and Revenue (USD Million) for 2018-2030
- 13.11.2.2 Livestock
- 13.11.2.2.1 Netherlands Livestock Market Share and Revenue (USD Million) for 2018-2030
- 13.11.2.1 Companion
- 13.11.1 Netherlands Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.12 Switzerland Veterinary Vaccine Market Size (2018-2030)
- 13.12.1 Switzerland Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.12.1.1 Inactivated Vaccines
- 13.12.1.1.1 Switzerland Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.12.1.2 Toxoid Vaccine
- 13.12.1.2.1 Switzerland Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 13.12.1.3 Live Attenuated Vaccines
- 13.12.1.3.1 Switzerland Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.12.1.4 Subunit and DNA Vaccines
- 13.12.1.4.1 Switzerland Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.12.1.1 Inactivated Vaccines
- 13.12.2 Switzerland Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 13.12.2.1 Companion
- 13.12.2.1.1 Switzerland Companion Market Share and Revenue (USD Million) for 2018-2030
- 13.12.2.2 Livestock
- 13.12.2.2.1 Switzerland Livestock Market Share and Revenue (USD Million) for 2018-2030
- 13.12.2.1 Companion
- 13.12.1 Switzerland Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.13 Belgium Veterinary Vaccine Market Size (2018-2030)
- 13.13.1 Belgium Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 13.13.1.1 Inactivated Vaccines
- 13.13.1.1.1 Belgium Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.13.1.2 Toxoid Vaccine
- 13.13.1.2.1 Belgium Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 13.13.1.3 Live Attenuated Vaccines
- 13.13.1.3.1 Belgium Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.13.1.4 Subunit and DNA Vaccines
- 13.13.1.4.1 Belgium Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 13.13.1.1 Inactivated Vaccines
- 13.13.2 Belgium Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 13.13.2.1 Companion
- 13.13.2.1.1 Belgium Companion Market Share and Revenue (USD Million) for 2018-2030
- 13.13.2.2 Livestock
- 13.13.2.2.1 Belgium Livestock Market Share and Revenue (USD Million) for 2018-2030
- 13.13.2.1 Companion
- 13.13.1 Belgium Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.1 Asia Pacific
- 14.1.1 Asia Pacific Veterinary Vaccine Market Trends and Analysis
- 14.1.2 Asia Pacific Veterinary Vaccine Market by Country, 2018-2030
- 14.1.3 Asia Pacific Veterinary Vaccine Market Attractiveness Analysis by Country
- 14.2 Asia Pacific Veterinary Vaccine Market Size (2018-2030)
- 14.2.1 Asia Pacific Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.2.1.1 Inactivated Vaccines
- 14.2.1.1.1 Asia Pacific Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Toxoid Vaccine
- 14.2.1.2.1 Asia Pacific Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.3 Live Attenuated Vaccines
- 14.2.1.3.1 Asia Pacific Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.4 Subunit and DNA Vaccines
- 14.2.1.4.1 Asia Pacific Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.1 Inactivated Vaccines
- 14.2.2 Asia Pacific Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 14.2.2.1 Companion
- 14.2.2.1.1 Asia Pacific Companion Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Livestock
- 14.2.2.2.1 Asia Pacific Livestock Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.1 Companion
- 14.2.1 Asia Pacific Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.3 China Veterinary Vaccine Market Size (2018-2030)
- 14.3.1 China Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.3.1.1 Inactivated Vaccines
- 14.3.1.1.1 China Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.3.1.2 Toxoid Vaccine
- 14.3.1.2.1 China Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 14.3.1.3 Live Attenuated Vaccines
- 14.3.1.3.1 China Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.3.1.4 Subunit and DNA Vaccines
- 14.3.1.4.1 China Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.3.1.1 Inactivated Vaccines
- 14.3.2 China Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 14.3.2.1 Companion
- 14.3.2.1.1 China Companion Market Share and Revenue (USD Million) for 2018-2030
- 14.3.2.2 Livestock
- 14.3.2.2.1 China Livestock Market Share and Revenue (USD Million) for 2018-2030
- 14.3.2.1 Companion
- 14.3.1 China Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.4 Japan Veterinary Vaccine Market Size (2018-2030)
- 14.4.1 Japan Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.4.1.1 Inactivated Vaccines
- 14.4.1.1.1 Japan Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.4.1.2 Toxoid Vaccine
- 14.4.1.2.1 Japan Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 14.4.1.3 Live Attenuated Vaccines
- 14.4.1.3.1 Japan Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.4.1.4 Subunit and DNA Vaccines
- 14.4.1.4.1 Japan Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.4.1.1 Inactivated Vaccines
- 14.4.2 Japan Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 14.4.2.1 Companion
- 14.4.2.1.1 Japan Companion Market Share and Revenue (USD Million) for 2018-2030
- 14.4.2.2 Livestock
- 14.4.2.2.1 Japan Livestock Market Share and Revenue (USD Million) for 2018-2030
- 14.4.2.1 Companion
- 14.4.1 Japan Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.5 Korea Veterinary Vaccine Market Size (2018-2030)
- 14.5.1 Korea Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.5.1.1 Inactivated Vaccines
- 14.5.1.1.1 Korea Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.5.1.2 Toxoid Vaccine
- 14.5.1.2.1 Korea Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 14.5.1.3 Live Attenuated Vaccines
- 14.5.1.3.1 Korea Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.5.1.4 Subunit and DNA Vaccines
- 14.5.1.4.1 Korea Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.5.1.1 Inactivated Vaccines
- 14.5.2 Korea Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 14.5.2.1 Companion
- 14.5.2.1.1 Korea Companion Market Share and Revenue (USD Million) for 2018-2030
- 14.5.2.2 Livestock
- 14.5.2.2.1 Korea Livestock Market Share and Revenue (USD Million) for 2018-2030
- 14.5.2.1 Companion
- 14.5.1 Korea Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.6 India Veterinary Vaccine Market Size (2018-2030)
- 14.6.1 India Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.6.1.1 Inactivated Vaccines
- 14.6.1.1.1 India Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.6.1.2 Toxoid Vaccine
- 14.6.1.2.1 India Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 14.6.1.3 Live Attenuated Vaccines
- 14.6.1.3.1 India Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.6.1.4 Subunit and DNA Vaccines
- 14.6.1.4.1 India Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.6.1.1 Inactivated Vaccines
- 14.6.2 India Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 14.6.2.1 Companion
- 14.6.2.1.1 India Companion Market Share and Revenue (USD Million) for 2018-2030
- 14.6.2.2 Livestock
- 14.6.2.2.1 India Livestock Market Share and Revenue (USD Million) for 2018-2030
- 14.6.2.1 Companion
- 14.6.1 India Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.7 Australia Veterinary Vaccine Market Size (2018-2030)
- 14.7.1 Australia Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.7.1.1 Inactivated Vaccines
- 14.7.1.1.1 Australia Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.7.1.2 Toxoid Vaccine
- 14.7.1.2.1 Australia Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 14.7.1.3 Live Attenuated Vaccines
- 14.7.1.3.1 Australia Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.7.1.4 Subunit and DNA Vaccines
- 14.7.1.4.1 Australia Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.7.1.1 Inactivated Vaccines
- 14.7.2 Australia Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 14.7.2.1 Companion
- 14.7.2.1.1 Australia Companion Market Share and Revenue (USD Million) for 2018-2030
- 14.7.2.2 Livestock
- 14.7.2.2.1 Australia Livestock Market Share and Revenue (USD Million) for 2018-2030
- 14.7.2.1 Companion
- 14.7.1 Australia Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.8 Philippines Veterinary Vaccine Market Size (2018-2030)
- 14.8.1 Philippines Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.8.1.1 Inactivated Vaccines
- 14.8.1.1.1 Philippines Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.8.1.2 Toxoid Vaccine
- 14.8.1.2.1 Philippines Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 14.8.1.3 Live Attenuated Vaccines
- 14.8.1.3.1 Philippines Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.8.1.4 Subunit and DNA Vaccines
- 14.8.1.4.1 Philippines Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.8.1.1 Inactivated Vaccines
- 14.8.2 Philippines Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 14.8.2.1 Companion
- 14.8.2.1.1 Philippines Companion Market Share and Revenue (USD Million) for 2018-2030
- 14.8.2.2 Livestock
- 14.8.2.2.1 Philippines Livestock Market Share and Revenue (USD Million) for 2018-2030
- 14.8.2.1 Companion
- 14.8.1 Philippines Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.9 Singapore Veterinary Vaccine Market Size (2018-2030)
- 14.9.1 Singapore Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.9.1.1 Inactivated Vaccines
- 14.9.1.1.1 Singapore Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.9.1.2 Toxoid Vaccine
- 14.9.1.2.1 Singapore Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 14.9.1.3 Live Attenuated Vaccines
- 14.9.1.3.1 Singapore Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.9.1.4 Subunit and DNA Vaccines
- 14.9.1.4.1 Singapore Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.9.1.1 Inactivated Vaccines
- 14.9.2 Singapore Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 14.9.2.1 Companion
- 14.9.2.1.1 Singapore Companion Market Share and Revenue (USD Million) for 2018-2030
- 14.9.2.2 Livestock
- 14.9.2.2.1 Singapore Livestock Market Share and Revenue (USD Million) for 2018-2030
- 14.9.2.1 Companion
- 14.9.1 Singapore Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.10 Malaysia Veterinary Vaccine Market Size (2018-2030)
- 14.10.1 Malaysia Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.10.1.1 Inactivated Vaccines
- 14.10.1.1.1 Malaysia Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.10.1.2 Toxoid Vaccine
- 14.10.1.2.1 Malaysia Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 14.10.1.3 Live Attenuated Vaccines
- 14.10.1.3.1 Malaysia Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.10.1.4 Subunit and DNA Vaccines
- 14.10.1.4.1 Malaysia Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.10.1.1 Inactivated Vaccines
- 14.10.2 Malaysia Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 14.10.2.1 Companion
- 14.10.2.1.1 Malaysia Companion Market Share and Revenue (USD Million) for 2018-2030
- 14.10.2.2 Livestock
- 14.10.2.2.1 Malaysia Livestock Market Share and Revenue (USD Million) for 2018-2030
- 14.10.2.1 Companion
- 14.10.1 Malaysia Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.11 Thailand Veterinary Vaccine Market Size (2018-2030)
- 14.11.1 Thailand Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.11.1.1 Inactivated Vaccines
- 14.11.1.1.1 Thailand Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.11.1.2 Toxoid Vaccine
- 14.11.1.2.1 Thailand Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 14.11.1.3 Live Attenuated Vaccines
- 14.11.1.3.1 Thailand Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.11.1.4 Subunit and DNA Vaccines
- 14.11.1.4.1 Thailand Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.11.1.1 Inactivated Vaccines
- 14.11.2 Thailand Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 14.11.2.1 Companion
- 14.11.2.1.1 Thailand Companion Market Share and Revenue (USD Million) for 2018-2030
- 14.11.2.2 Livestock
- 14.11.2.2.1 Thailand Livestock Market Share and Revenue (USD Million) for 2018-2030
- 14.11.2.1 Companion
- 14.11.1 Thailand Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.12 Indonesia Veterinary Vaccine Market Size (2018-2030)
- 14.12.1 Indonesia Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.12.1.1 Inactivated Vaccines
- 14.12.1.1.1 Indonesia Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.12.1.2 Toxoid Vaccine
- 14.12.1.2.1 Indonesia Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 14.12.1.3 Live Attenuated Vaccines
- 14.12.1.3.1 Indonesia Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.12.1.4 Subunit and DNA Vaccines
- 14.12.1.4.1 Indonesia Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.12.1.1 Inactivated Vaccines
- 14.12.2 Indonesia Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 14.12.2.1 Companion
- 14.12.2.1.1 Indonesia Companion Market Share and Revenue (USD Million) for 2018-2030
- 14.12.2.2 Livestock
- 14.12.2.2.1 Indonesia Livestock Market Share and Revenue (USD Million) for 2018-2030
- 14.12.2.1 Companion
- 14.12.1 Indonesia Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.13 Rest of APAC Veterinary Vaccine Market Size (2018-2030)
- 14.13.1 Rest of APAC Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 14.13.1.1 Inactivated Vaccines
- 14.13.1.1.1 Rest of APAC Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.13.1.2 Toxoid Vaccine
- 14.13.1.2.1 Rest of APAC Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 14.13.1.3 Live Attenuated Vaccines
- 14.13.1.3.1 Rest of APAC Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.13.1.4 Subunit and DNA Vaccines
- 14.13.1.4.1 Rest of APAC Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 14.13.1.1 Inactivated Vaccines
- 14.13.2 Rest of APAC Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 14.13.2.1 Companion
- 14.13.2.1.1 Rest of APAC Companion Market Share and Revenue (USD Million) for 2018-2030
- 14.13.2.2 Livestock
- 14.13.2.2.1 Rest of APAC Livestock Market Share and Revenue (USD Million) for 2018-2030
- 14.13.2.1 Companion
- 14.13.1 Rest of APAC Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.1 Latin America
- 15.1.1 Latin America Veterinary Vaccine Market Trends and Analysis
- 15.1.2 Latin America Veterinary Vaccine Market by Country, 2018-2030
- 15.1.3 Latin America Veterinary Vaccine Market Attractiveness Analysis by Country
- 15.2 Latin America Veterinary Vaccine Market Size (2018-2030)
- 15.2.1 Latin America Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.2.1.1 Inactivated Vaccines
- 15.2.1.1.1 Latin America Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.2 Toxoid Vaccine
- 15.2.1.2.1 Latin America Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.3 Live Attenuated Vaccines
- 15.2.1.3.1 Latin America Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.4 Subunit and DNA Vaccines
- 15.2.1.4.1 Latin America Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.2.1.1 Inactivated Vaccines
- 15.2.2 Latin America Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 15.2.2.1 Companion
- 15.2.2.1.1 Latin America Companion Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.2 Livestock
- 15.2.2.2.1 Latin America Livestock Market Share and Revenue (USD Million) for 2018-2030
- 15.2.2.1 Companion
- 15.2.1 Latin America Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.3 Brazil Veterinary Vaccine Market Size (2018-2030)
- 15.3.1 Brazil Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.3.1.1 Inactivated Vaccines
- 15.3.1.1.1 Brazil Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.2 Toxoid Vaccine
- 15.3.1.2.1 Brazil Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.3 Live Attenuated Vaccines
- 15.3.1.3.1 Brazil Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.4 Subunit and DNA Vaccines
- 15.3.1.4.1 Brazil Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.3.1.1 Inactivated Vaccines
- 15.3.2 Brazil Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 15.3.2.1 Companion
- 15.3.2.1.1 Brazil Companion Market Share and Revenue (USD Million) for 2018-2030
- 15.3.2.2 Livestock
- 15.3.2.2.1 Brazil Livestock Market Share and Revenue (USD Million) for 2018-2030
- 15.3.2.1 Companion
- 15.3.1 Brazil Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.4 Argentina Veterinary Vaccine Market Size (2018-2030)
- 15.4.1 Argentina Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.4.1.1 Inactivated Vaccines
- 15.4.1.1.1 Argentina Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.2 Toxoid Vaccine
- 15.4.1.2.1 Argentina Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.3 Live Attenuated Vaccines
- 15.4.1.3.1 Argentina Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.4 Subunit and DNA Vaccines
- 15.4.1.4.1 Argentina Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.4.1.1 Inactivated Vaccines
- 15.4.2 Argentina Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 15.4.2.1 Companion
- 15.4.2.1.1 Argentina Companion Market Share and Revenue (USD Million) for 2018-2030
- 15.4.2.2 Livestock
- 15.4.2.2.1 Argentina Livestock Market Share and Revenue (USD Million) for 2018-2030
- 15.4.2.1 Companion
- 15.4.1 Argentina Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.5 Colombia Veterinary Vaccine Market Size (2018-2030)
- 15.5.1 Colombia Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.5.1.1 Inactivated Vaccines
- 15.5.1.1.1 Colombia Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.2 Toxoid Vaccine
- 15.5.1.2.1 Colombia Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.3 Live Attenuated Vaccines
- 15.5.1.3.1 Colombia Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.4 Subunit and DNA Vaccines
- 15.5.1.4.1 Colombia Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.5.1.1 Inactivated Vaccines
- 15.5.2 Colombia Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 15.5.2.1 Companion
- 15.5.2.1.1 Colombia Companion Market Share and Revenue (USD Million) for 2018-2030
- 15.5.2.2 Livestock
- 15.5.2.2.1 Colombia Livestock Market Share and Revenue (USD Million) for 2018-2030
- 15.5.2.1 Companion
- 15.5.1 Colombia Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.6 Peru Veterinary Vaccine Market Size (2018-2030)
- 15.6.1 Peru Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.6.1.1 Inactivated Vaccines
- 15.6.1.1.1 Peru Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.6.1.2 Toxoid Vaccine
- 15.6.1.2.1 Peru Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 15.6.1.3 Live Attenuated Vaccines
- 15.6.1.3.1 Peru Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.6.1.4 Subunit and DNA Vaccines
- 15.6.1.4.1 Peru Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.6.1.1 Inactivated Vaccines
- 15.6.2 Peru Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 15.6.2.1 Companion
- 15.6.2.1.1 Peru Companion Market Share and Revenue (USD Million) for 2018-2030
- 15.6.2.2 Livestock
- 15.6.2.2.1 Peru Livestock Market Share and Revenue (USD Million) for 2018-2030
- 15.6.2.1 Companion
- 15.6.1 Peru Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.7 Chile Veterinary Vaccine Market Size (2018-2030)
- 15.7.1 Chile Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.7.1.1 Inactivated Vaccines
- 15.7.1.1.1 Chile Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.7.1.2 Toxoid Vaccine
- 15.7.1.2.1 Chile Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 15.7.1.3 Live Attenuated Vaccines
- 15.7.1.3.1 Chile Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.7.1.4 Subunit and DNA Vaccines
- 15.7.1.4.1 Chile Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.7.1.1 Inactivated Vaccines
- 15.7.2 Chile Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 15.7.2.1 Companion
- 15.7.2.1.1 Chile Companion Market Share and Revenue (USD Million) for 2018-2030
- 15.7.2.2 Livestock
- 15.7.2.2.1 Chile Livestock Market Share and Revenue (USD Million) for 2018-2030
- 15.7.2.1 Companion
- 15.7.1 Chile Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.8 Rest of South America Veterinary Vaccine Market Size (2018-2030)
- 15.8.1 Rest of South America Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 15.8.1.1 Inactivated Vaccines
- 15.8.1.1.1 Rest of South America Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.8.1.2 Toxoid Vaccine
- 15.8.1.2.1 Rest of South America Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 15.8.1.3 Live Attenuated Vaccines
- 15.8.1.3.1 Rest of South America Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.8.1.4 Subunit and DNA Vaccines
- 15.8.1.4.1 Rest of South America Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 15.8.1.1 Inactivated Vaccines
- 15.8.2 Rest of South America Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 15.8.2.1 Companion
- 15.8.2.1.1 Rest of South America Companion Market Share and Revenue (USD Million) for 2018-2030
- 15.8.2.2 Livestock
- 15.8.2.2.1 Rest of South America Livestock Market Share and Revenue (USD Million) for 2018-2030
- 15.8.2.1 Companion
- 15.8.1 Rest of South America Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.1 Middle East and Africa
- 16.1.1 Middle East and Africa Veterinary Vaccine Market Trends and Analysis
- 16.1.2 Middle East and Africa Veterinary Vaccine Market by Country, 2018-2030
- 16.1.3 Middle East and Africa Veterinary Vaccine Market Attractiveness Analysis by Country
- 16.2 Middle East and Africa Veterinary Vaccine Market Size (2018-2030)
- 16.2.1 Middle East and Africa Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.2.1.1 Inactivated Vaccines
- 16.2.1.1.1 Middle East and Africa Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.2 Toxoid Vaccine
- 16.2.1.2.1 Middle East and Africa Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.3 Live Attenuated Vaccines
- 16.2.1.3.1 Middle East and Africa Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.4 Subunit and DNA Vaccines
- 16.2.1.4.1 Middle East and Africa Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.1 Inactivated Vaccines
- 16.2.2 Middle East and Africa Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 16.2.2.1 Companion
- 16.2.2.1.1 Middle East and Africa Companion Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.2 Livestock
- 16.2.2.2.1 Middle East and Africa Livestock Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.1 Companion
- 16.2.1 Middle East and Africa Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.3 Saudi Arabia Veterinary Vaccine Market Size (2018-2030)
- 16.3.1 Saudi Arabia Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.3.1.1 Inactivated Vaccines
- 16.3.1.1.1 Saudi Arabia Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.2 Toxoid Vaccine
- 16.3.1.2.1 Saudi Arabia Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.3 Live Attenuated Vaccines
- 16.3.1.3.1 Saudi Arabia Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.4 Subunit and DNA Vaccines
- 16.3.1.4.1 Saudi Arabia Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.1 Inactivated Vaccines
- 16.3.2 Saudi Arabia Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 16.3.2.1 Companion
- 16.3.2.1.1 Saudi Arabia Companion Market Share and Revenue (USD Million) for 2018-2030
- 16.3.2.2 Livestock
- 16.3.2.2.1 Saudi Arabia Livestock Market Share and Revenue (USD Million) for 2018-2030
- 16.3.2.1 Companion
- 16.3.1 Saudi Arabia Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.4 Turkey Veterinary Vaccine Market Size (2018-2030)
- 16.4.1 Turkey Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.4.1.1 Inactivated Vaccines
- 16.4.1.1.1 Turkey Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.2 Toxoid Vaccine
- 16.4.1.2.1 Turkey Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.3 Live Attenuated Vaccines
- 16.4.1.3.1 Turkey Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.4 Subunit and DNA Vaccines
- 16.4.1.4.1 Turkey Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.1 Inactivated Vaccines
- 16.4.2 Turkey Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 16.4.2.1 Companion
- 16.4.2.1.1 Turkey Companion Market Share and Revenue (USD Million) for 2018-2030
- 16.4.2.2 Livestock
- 16.4.2.2.1 Turkey Livestock Market Share and Revenue (USD Million) for 2018-2030
- 16.4.2.1 Companion
- 16.4.1 Turkey Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.5 Nigeria Veterinary Vaccine Market Size (2018-2030)
- 16.5.1 Nigeria Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.5.1.1 Inactivated Vaccines
- 16.5.1.1.1 Nigeria Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.2 Toxoid Vaccine
- 16.5.1.2.1 Nigeria Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.3 Live Attenuated Vaccines
- 16.5.1.3.1 Nigeria Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.4 Subunit and DNA Vaccines
- 16.5.1.4.1 Nigeria Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.1 Inactivated Vaccines
- 16.5.2 Nigeria Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 16.5.2.1 Companion
- 16.5.2.1.1 Nigeria Companion Market Share and Revenue (USD Million) for 2018-2030
- 16.5.2.2 Livestock
- 16.5.2.2.1 Nigeria Livestock Market Share and Revenue (USD Million) for 2018-2030
- 16.5.2.1 Companion
- 16.5.1 Nigeria Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.6 UAE Veterinary Vaccine Market Size (2018-2030)
- 16.6.1 UAE Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.6.1.1 Inactivated Vaccines
- 16.6.1.1.1 UAE Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.2 Toxoid Vaccine
- 16.6.1.2.1 UAE Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.3 Live Attenuated Vaccines
- 16.6.1.3.1 UAE Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.4 Subunit and DNA Vaccines
- 16.6.1.4.1 UAE Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.6.1.1 Inactivated Vaccines
- 16.6.2 UAE Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 16.6.2.1 Companion
- 16.6.2.1.1 UAE Companion Market Share and Revenue (USD Million) for 2018-2030
- 16.6.2.2 Livestock
- 16.6.2.2.1 UAE Livestock Market Share and Revenue (USD Million) for 2018-2030
- 16.6.2.1 Companion
- 16.6.1 UAE Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.7 Egypt Veterinary Vaccine Market Size (2018-2030)
- 16.7.1 Egypt Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.7.1.1 Inactivated Vaccines
- 16.7.1.1.1 Egypt Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.2 Toxoid Vaccine
- 16.7.1.2.1 Egypt Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.3 Live Attenuated Vaccines
- 16.7.1.3.1 Egypt Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.4 Subunit and DNA Vaccines
- 16.7.1.4.1 Egypt Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.7.1.1 Inactivated Vaccines
- 16.7.2 Egypt Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 16.7.2.1 Companion
- 16.7.2.1.1 Egypt Companion Market Share and Revenue (USD Million) for 2018-2030
- 16.7.2.2 Livestock
- 16.7.2.2.1 Egypt Livestock Market Share and Revenue (USD Million) for 2018-2030
- 16.7.2.1 Companion
- 16.7.1 Egypt Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.8 South Africa Veterinary Vaccine Market Size (2018-2030)
- 16.8.1 South Africa Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.8.1.1 Inactivated Vaccines
- 16.8.1.1.1 South Africa Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.2 Toxoid Vaccine
- 16.8.1.2.1 South Africa Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.3 Live Attenuated Vaccines
- 16.8.1.3.1 South Africa Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.4 Subunit and DNA Vaccines
- 16.8.1.4.1 South Africa Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.8.1.1 Inactivated Vaccines
- 16.8.2 South Africa Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 16.8.2.1 Companion
- 16.8.2.1.1 South Africa Companion Market Share and Revenue (USD Million) for 2018-2030
- 16.8.2.2 Livestock
- 16.8.2.2.1 South Africa Livestock Market Share and Revenue (USD Million) for 2018-2030
- 16.8.2.1 Companion
- 16.8.1 South Africa Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.9 GCC Countries Veterinary Vaccine Market Size (2018-2030)
- 16.9.1 GCC Countries Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.9.1.1 Inactivated Vaccines
- 16.9.1.1.1 GCC Countries Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.2 Toxoid Vaccine
- 16.9.1.2.1 GCC Countries Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.3 Live Attenuated Vaccines
- 16.9.1.3.1 GCC Countries Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.4 Subunit and DNA Vaccines
- 16.9.1.4.1 GCC Countries Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.9.1.1 Inactivated Vaccines
- 16.9.2 GCC Countries Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 16.9.2.1 Companion
- 16.9.2.1.1 GCC Countries Companion Market Share and Revenue (USD Million) for 2018-2030
- 16.9.2.2 Livestock
- 16.9.2.2.1 GCC Countries Livestock Market Share and Revenue (USD Million) for 2018-2030
- 16.9.2.1 Companion
- 16.9.1 GCC Countries Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.10 Rest of MEA Veterinary Vaccine Market Size (2018-2030)
- 16.10.1 Rest of MEA Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 16.10.1.1 Inactivated Vaccines
- 16.10.1.1.1 Rest of MEA Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.2 Toxoid Vaccine
- 16.10.1.2.1 Rest of MEA Toxoid Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.3 Live Attenuated Vaccines
- 16.10.1.3.1 Rest of MEA Live Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.4 Subunit and DNA Vaccines
- 16.10.1.4.1 Rest of MEA Subunit and DNA Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.10.1.1 Inactivated Vaccines
- 16.10.2 Rest of MEA Veterinary Vaccine Market (USD Million) by Animal Type (2018-2030)
- 16.10.2.1 Companion
- 16.10.2.1.1 Rest of MEA Companion Market Share and Revenue (USD Million) for 2018-2030
- 16.10.2.2 Livestock
- 16.10.2.2.1 Rest of MEA Livestock Market Share and Revenue (USD Million) for 2018-2030
- 16.10.2.1 Companion
- 16.10.1 Rest of MEA Veterinary Vaccine Market (USD Million) by Technology (2018-2030)
- 17.1 Key Takeaways
- 17.2 Analyst Point of View
Segmentation Level Customization | |
Global level Data Customization | |
Region level Data Customization | |
Country level Data Customization | |
Company Level | |
Additional Data Analysis | |
Additional Qualitative Data | |
Additional Quantitative Data | |
Service Level Customization | Report Format Alteration |
We have various report editions of Veterinary Vaccine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Veterinary Vaccine Market Analysis
Global Veterinary Vaccine Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Veterinary Vaccine Industry growth. Veterinary Vaccine market has been segmented with the help of its Technology, Animal Type , and others. Veterinary Vaccine market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Report scope is customizable as we have a huge database of Veterinary Vaccine industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Major Technology Analysed | |
Major Animal Type Analysed | |
Top Manufacturers Disclosed | |
Global, Regional and Country Analysis |
|
Key Qualitative Information Covered |
|
Veterinary Vaccine Market, By Technology
- Inactivated Vaccines
- Toxoid Vaccine
- Live Attenuated Vaccines
- Subunit and DNA Vaccines
Live Attenuated Vaccines dominate the global veterinary vaccines market in terms of growth rate. Live attenuation is the oldest vaccination method used in the veterinary field.
Veterinary Vaccine Market Share (%) by Technology in 2018-2030
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Veterinary Vaccine Industry. Request a Free Sample PDF!
Veterinary Vaccine Market, By Animal Type
Companion
- Equine
- Canine
- Feline
Livestock
- Bovine
- Ovine
- Porcine
- Poultry
- Others
The livestock segment dominates the global market with the highest revenue share. supportive government initiatives, increasing livestock population, and the outbreak of diseases among cattle and sheep drive the demand for the global market.
Veterinary Vaccine Market Share (%) by Animal Type in 2018-2030
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Veterinary Vaccine market report 2023 Edition by contacting our team.
North America Veterinary Vaccine Market dominates the overall market.!
North America dominates the global veterinary vaccines market with the highest revenue share. This is attributed to the growing incidences of livestock and zoonotic diseases which have resulted in a large number of animal deaths in this region. Furthermore, Asia-Pacific is forecasted to dominate the global market in terms of growth rate. The rising livestock population drives the demand for the target market in the country in the region.
Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Veterinary Vaccine Market Share (%) by Region (2018-2030)
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
Veterinary Vaccine Industry News:
- Boehringer Ingelheim partnered with Henke-Sass Wolf.
In October 2020, Boehringer Ingelheim partnered with Henke-Sass Wolf to develop an innovative intramuscular needle-free vaccine injection tool for pigs around weaning until the end of their nursery.
https://www.boehringer-ingelheim.com/press-release/boehringer-ingelheim-henke-sass-wolf-develop-needle-free-device
Top Companies Market Share in Veterinary Vaccine Industry: (In no particular order of Rank)
- Merial
- Merck
- Boehringer Ingelheim
- Zoetis
- Virbac
- Ceva
- Elanco/Eli Lilly
- Sindh Poultry Vaccine Centre
- Bio Labs
- Vaksindo
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Veterinary Vaccine Market is witnessing significant growth in the near future.
In 2022, the Inactivated Vaccines segment accounted for noticeable share of global Veterinary Vaccine Market and is projected to experience significant growth in the near future.
The Companion segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Merial, Boehringer Ingelheim and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Author's Detail
Surabhi Bhaiyya, LinkedIn
Senior Research Analyst at Cognitive Market Research
Surabhi Bhaiyya is an experienced market researcher focused on the Pharma & Healthcare industry. With over 7+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry. To get in touch and access the above report book an apointment at https://calendly.com/speak-to-analyst.
Key Questions Answered By Veterinary Vaccine Market Report 2023
Why Inactivated Vaccines have a significant impact on Veterinary Vaccine market? |
What are the key factors affecting the Inactivated Vaccines and Toxoid Vaccine of Veterinary Vaccine Market? |
What is the CAGR/Growth Rate of Companion during the forecast period? |
By type, which segment accounted for largest share of the global Veterinary Vaccine Market? |
Which region is expected to dominate the global Veterinary Vaccine Market within the forecast period? |
Frequently Asked Questions
Related Reports
- Measures to Explore Untapped Market
- Understanding Market Dynamics
- Understanding Changing Economics
- Competitors Market Share
- Global/Region/Country Level Analysis
- Identify Upcoming End Use Industries
- Global Price Trend Analysis
- Value Chain Analysis
- Customer Sentiment/Need Analysis
- Identification of Key Growth Segments
- Industry Upstream and Downstream Analysis
- Raw Material Sourcing and Cost Analysis
- Identify Key Customers Across Globe
- Concept Development and Market Testing
- Merger-Acquisition Strategy
- The research study and report are been made exclusively for an institution or person who is strategizing to build a business or strategically wants to expand certain portfolio.
- This report will help in analyzing complete market scenario across the globe who wish to expand their current business or is willing to invest in some profitable sector.
- This report will prove beneficial for person or an organization who wish to be updated regarding their business environment, consumers’ behaviour, and their requirements. The environment is constantly changing, and in such scenario, this report will help in understanding market parameters through 360-degree view.
- The report is thus ideal for KOL, CEO's, CFO's, directors, and others. It is also helpful to senior executives, business development managers, marketing managers, and consultants. Furthermore, government bodies, agencies and other kind of organizations can also leverage our report to understand market.
- Our objective for the Veterinary Vaccine market is to help in making imperative business decisions, securing investments, determining new business opportunities in the market. Further, the report helps to analyze overall marketing needs of customers, and avoid business failures.
- To know the potential market size and growth rate before launching a new product line. The report in a way helps in designing R&D budget wisely by estimating maximum total profit.
- To identify the Veterinary Vaccine market dynamics, industrial insights, and economic progression for critical information about the market conditions and specific business landscape.
- To assess the overall competitive landscape of a particular business sector and to provide complete analysis in regards with various external factors impacting the market growth.
- To create a strong foundation for building a strategy and foster insight into market conditions so that market players can make better business decisions. Besides, we aim to provide a complete portfolio of the major players involved the market.
- To define the scope which will further help in creating new products that will surpass the gap between current offerings and customers’ needs.
- To help in revealing significant clues concerning buying habits, regional culture, lifestyle, and population density that plays an integral role in shaping market behavior.
- To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the total market.
- Competitors Analysis: We provide data from the supplier side covering key details such as market share split among 1st tier, 2nd tier, and 3rd tier, Emerging Players, and Start-Ups. (whereas most of our competitors published data for top-tier companies)
- We provide market revenue share not only for Public listed companies but also the privately listed companies.
- Country Analysis: The Country level market split analysis is part of the report hence the data granularity is provided.
- We have been closely working with the Top 500 Fortune businesses, our clientele spanning 20+ industries. Our clientele is a mix of investors, manufacturers, end-users, distributors, etc. With our data subscription model (Athenaeum) 70% of clients have already subscribed/purchased reports for multiple years which helped us achieve unbelievable client retention statistics.
- Product + Service: In terms of the product we deliver the report access (PDF+ PPT+ EXCEL+ Cloud+ POWER BI) whereas in terms of service; we provide data support where a dedicated research analyst will be assigned and add-on benefits. (Whereas most of our competitors believe only in delivering the data/report and service and support remain questionable.)
- Credibility and Data Accuracy: We deliver accuracy close to 90-95% with the help of our in-house research team, freelancer, and industry expert network, sources present worldwide. This Data is backed up by strong What are our clients saying about our services.
Read more